[TEAM HEALTH LOGO]

FOR IMMEDIATE RELEASE                          Contact:
---------------------                          John D. Lovallo
                                               Ogilvy Public Relations Worldwide
                                               212-880-5216
                                               john.lovallo@ogilvypr.com



                 Team Health, Inc. Extends Consent Solicitation


KNOXVILLE, Tenn., March 9, 2004 - Team Health, Inc. (the "Company") announced
today that it is extending the Consent Date with respect to its tender offer
(the "Offer") for any and all of its $100.0 million aggregate principal amount
of 12% Senior Subordinated Notes due 2009 (CUSIP No. 87815VAC7) (the "Notes")
from 5:00 p.m., New York City time, on Monday, March 8, 2004 to 5:00 p.m., New
York City time, on Thursday, March 11, 2004. As of March 8, 2004, the principal
amount of Notes tendered was approximately $53 million.

The Offer is scheduled to expire at 12:00 midnight, New York City time, on
Monday, March 22, 2004, unless extended or earlier terminated (the "Expiration
Date"). Holders tendering their Notes will be required to consent to certain
proposed amendments to the indenture governing the Notes, which will eliminate
substantially all of the restrictive covenants. Holders may not tender their
Notes without delivering consents or deliver consents without tendering their
Notes.

Holders who validly tender their notes by the Consent Date will receive the
total consideration of $1,082.50 per $1,000 principal amount of Notes (if such
notes are accepted for purchase). Holders who validly tender their Notes after
the Consent Date and prior to the Expiration Date will receive as payment for
the Notes $1,062.50 per $1,000 principal amount of Notes (if such notes are
accepted for purchase). In either case, Holders who validly tender their Notes
also will be paid accrued and unpaid interest up to, but not including, the date
of payment for the Notes (if such notes are accepted for purchase).




In addition to the Offer, the Company intends to (i) consummate a private
offering of a new series of senior subordinated notes, (ii) enter into new
senior secured credit facilities, (iii) redeem its outstanding preferred stock
and (iv) pay a dividend to holders of the Company's common stock (if approved by
the Company's board of directors). We refer to these transactions, collectively,
as the "Refinancing Transactions".

The Offer is subject to the satisfaction of certain conditions, including the
Company's receipt of tenders of Notes representing a majority of the principal
amount of the Notes outstanding and the consummation of the Refinancing
Transactions, and is expected to be financed by a combination of the new senior
subordinated notes and borrowings under the new credit facilities. The Company
currently plans to call for redemption, upon the closing of the new senior
subordinated notes offering and the new credit facilities, in accordance with
the terms of the indenture governing the Notes, all Notes that remain
outstanding. The terms of the Offer are described in the Company's Offer to
Purchase and Consent Solicitation Statement dated February 24, 2004, copies of
which may be obtained from Georgeson Shareholder Communications.

The Company has engaged J.P. Morgan Securities Inc. and Banc of America
Securities LLC to act as dealer managers and solicitation agents in connection
with the Offer. Questions regarding the Offer may be directed to J.P. Morgan
Securities Inc., Chad Joplin, at (212) 270-1171 (collect) and Banc of America
Securities LLC, High Yield Special Products, at (888)-292-0070 (toll-free) and
(212)-847-5834 (collect). Requests for documentation may be directed to
Georgeson Shareholder Communications, the information agent for the Offer, at
(866) 399-8793 (toll-free) and (212) 440-9800.

The announcement is not an offer to purchase, a solicitation of an offer to
purchase or a solicitation of consent with respect to any securities. The Offer
is being made solely by the Offer to Purchase and Consent Solicitation Statement
dated February 24, 2004.

The Company will be issuing the new senior subordinated notes in a transaction
that will not be and has not been registered under the Securities Act of 1933,
as amended, or any state securities laws and the new notes may not be offered or
sold in the United States absent registration or an applicable exemption from
the registration requirements of the Securities Act and applicable state
securities laws. This press release does not constitute an offer to sell or the
solicitation of an offer to buy any security.

                                      ###


                                      -2-